Examples of Kyowa in a sentence
They will be focused on enhancing knowledge on matters dealt with in the CSCE among, inter alia, civil servants, the media and the public at large.
Valeant will hold the exclusive rights to develop and commercialise brodalumab globally, except in Japan and certain other Asian countries where rights are held by Kyowa Hakko Kirin under a prior arrangement with Amgen (NASDAQ:AMGN), the US pharmaceuticals developer that originated brodalumab.
August 2015 | News | By BioSpectrum Bureau Kyowa Hakko Kirin to commercialize AstraZeneca's asthma drug in Japan Tokyo: Global pharmaceutical company AstraZeneca has entered into an agreement with Kyowa Hakko Kirin Co. Ltd.
The transaction will be subject to customary closing conditions including approval by Lupin’s shareholders.Under the terms of the agreement, Lupin’s subsidiary Nanomi B.V. will divest its entire stake (99.82%) in Kyowa to Unison’s entity Plutus Ltd.
November 2019 | News | By Ayesha Siddiqui Lupin enters into agreement to divest its stake in Kyowa to Unison Indian pharma major Lupin Limited (including its subsidiaries, together referred to as ‘Lupin’) announced that it has entered into a definitive agreement for the sale of its entire stake in its Japanese subsidiary Kyowa Pharmaceutical Industry Co., Ltd.
December 2012 | News | By BioSpectrum Bureau Genmab in research collaboration with Japan company Kyowa Hakko Kirin Singapore: Genmab has entered into a research collaboration with Japan-based Kyowa Hakko Kirin to create bispecific antibodies using Genmab's DuoBody technology.
Surface tensions of aqueous surfactant solutions were measured using a Wilhelmy tensiometer (CBVP-Z, Kyowa Interface Science) equipped with a platinum plate.
Once my Protected Health Information has been disclosed to Kyowa Kirin, I understand that federal privacy laws no longer protect the information.
Dr. Kalunian has received grants from UCB, Human Genome Sciences/GlaxoSmithKline, Takeda, Ablynx, Bristol-Myers Squibb, Pfizer, and Kyowa Hakko Kirin, and has received consulting fees from Exagen Diagnostics, Genentech, Eli Lilly, Bristol-Myers Squibb, and Anthera (less than $10,000 each).
Kyowa Hakko Kirin operates an ethical pharmaceuticals business and is a core company within the Pharmaceuticals Business division of Kirin Holdings.